Granulocyte-macrophage colony-stimulating factor reverses Alzheimer's disease pathology in the tgf344-AD rat model.
Alzheimer's & dementia : the journal of the Alzheimer's Association(2021)
Abstract
Although experiments are in progress, our preliminary findings indicate that GM-CSF treatment rescues some AD pathology in TgF344-AD rats. Complete results will determine the therapeutic potential for GM-CSF/sargramostim/Leukine® not only for reducing amyloidosis, but also on other relevant pathological manifestations of AD.
MoreTranslated text
Key words
alzheimer,granulocyte-macrophage,colony-stimulating
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined